BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Product: MST Continus

Presentation	Product	Chemical substance	Chapter	Items dispensed
MST Continus 10mg tablets 0407020Q0BBAAAK	MST Continus	Morphine sulfate	Central Nervous System	32,381
MST Continus 5mg tablets 0407020Q0BBAKCG	MST Continus	Morphine sulfate	Central Nervous System	29,467
MST Continus 30mg tablets 0407020Q0BBABAL	MST Continus	Morphine sulfate	Central Nervous System	19,795
MST Continus 15mg tablets 0407020Q0BBALCF	MST Continus	Morphine sulfate	Central Nervous System	16,202
MST Continus 60mg tablets 0407020Q0BBACAI	MST Continus	Morphine sulfate	Central Nervous System	7,691
MST Continus 100mg tablets 0407020Q0BBADAH	MST Continus	Morphine sulfate	Central Nervous System	2,447
MST Continus 200mg tablets 0407020Q0BBAEAG	MST Continus	Morphine sulfate	Central Nervous System	377
MST Continus suspension 20mg granules sachets 0407020Q0BBAFCV	MST Continus	Morphine sulfate	Central Nervous System	325
MST Continus suspension 30mg granules sachets 0407020Q0BBAGCP	MST Continus	Morphine sulfate	Central Nervous System	161
MST Continus suspension 60mg granules sachets 0407020Q0BBAHDC	MST Continus	Morphine sulfate	Central Nervous System	66
MST Continus suspension 100mg granules sachets 0407020Q0BBAIDD	MST Continus	Morphine sulfate	Central Nervous System	30
MST Continus suspension 200mg granules sachets 0407020Q0BBAJDE	MST Continus	Morphine sulfate	Central Nervous System	8

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.